Mutations in BRAF, most frequently the valine (V) to glutamate (E) substitution at residue 600 (V600E), are identified as cancer-causing mutations in thyroid carcinoma (THCA) and skin cutaneous melanoma (SKCM). The gene discussed is BRAF; the disease is cancer.